A new test could be more effective at detecting dangerous prostate cancer than current screening methods, a study suggests.
Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...
New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...
A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...
The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...
The Korean Urological Oncology Society (President Jeong Byeong-chang) held a press conference at the Korea Press Center on ...
Black individuals in the United States continue to experience the highest rates of prostate cancer diagnosis and death. Even though the prostate-specific antigen (PSA) test, a validated diagnostic ...